"Elimination of TBI from the RIC regimen for DC/TBD was not associated with significant changes in rates of graft failure, ...

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan ...

A chimera is an organism composed of cells from two or more distinct genotypes. Human-animal chimeras are a budding area of research and involve the introduction and growth of human tissues in an ...

TScan Therapeutics (TCRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sam ...

Donor lymphocyte infusion, both alone and in combination with azacitidine, restored CD34 levels in two-thirds of patients with a baseline CD34 donor chimerism of less than 80%. Recent years have ...

Additionally, those receiving the treatment achieved full chimerism and minimal residual disease negativity, indicating strong efficacy. The safety profile was comparable between the treatment and ...

The use of polyclonal antibody preparations for immunosuppressive therapy in transplantation has been widely accepted for more than 2 decades. The earliest antibodies used in transplantation were ...

Skeletal stem cells have been isolated from various tissues, including periosteum and bone marrow, where they exhibit key functions in bone biology and hematopoiesis, respectively. The role of ...

The first CI used in transplantation, CsA, was approved by the US Food and Drug Administration in 1983. CsA was rapidly adopted into immunosuppressive regimens. The results of early pivotal ...

Embrace Pet Insurance offers coverage for dogs and cats and reimburses pet owners for preventative veterinary care, grooming and behavioral training with no per-item limits. Embrace charges a ...